Viewing data from:

METHOCARBAMOL

ANDA

METHOCARBAMOL | A212623 | POINTVIEW HOLDINGS LLC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 4 NDCs

Highest NADAC/Unit

$0.0424

per ea

Lowest NADAC/Unit

$0.0397

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
63561017401METHOCARBAMOL 750 MG TABLET	$0.0424	EA	Generic	—	2026-08-19
63561017405METHOCARBAMOL 750 MG TABLET	$0.0424	EA	Generic	—	2026-08-19
63561017301METHOCARBAMOL 500 MG TABLET	$0.0397	EA	Generic	—	2026-08-19
63561017305METHOCARBAMOL 500 MG TABLET	$0.0397	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 15 NDCs (15 FSS)

Lowest Price

$4.00

Highest Price

$38.82

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
72162-2487-01METHOCARBAMOL 500MG TAB	$6.64	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
72162-2487-05METHOCARBAMOL 500MG TAB	$28.79	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
72162-2488-01METHOCARBAMOL 750MG TAB	$8.53	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
72162-2488-05METHOCARBAMOL 750MG TAB	$38.82	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
72789-0481-01METHOCARBAMOL 500MG TAB	$4.99	FSS	PD-Rx Pharmaceuticals, Inc.	05/31/2026
72789-0481-30METHOCARBAMOL 500MG TAB	$4.00	FSS	PD-Rx Pharmaceuticals, Inc.	05/31/2026

Showing 6 of 15 NDCs.

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain10 active DMFs21 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

BOEHRINGER INGELHEIM CHEMICALS INCMETHOCARBAMOL

DMF 59541985

SYNTHOKEM LABS PRIVATE LTDMETHOCARBAMOL USP

DMF 104101993

SEVEN STAR PHARMACEUTICAL CO LTDMETHOCARBAMOL

DMF 155962001

GRANULES INDIA LTDMETHOCARBAMOL USP

DMF 178722004

ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO LTDMETHOCARBAMOL API

DMF 196572006

ZHEJIANG HAIZHOU PHARMACEUTICAL CO LTDMETHOCARBAMOL USP

DMF 311122016

ZHEJIANG HAIZHOU PHARMACEUTICAL CO LTDMETHOCARBAMOL

DMF 336592019

ZHEJIANG HAIZHOU PHARMACEUTICAL CO LTDMETHOCARBAMOL (PROCESS ISOPROPANOL)

DMF 374362023

DELTA SYNTHETIC CO LTDMETHOCARBAMOL

DMF 386312023

APITORIA PHARMA PRIVATE LTDMETHOCARBAMOL USP

DMF 426542025

PENCO OF LYNDHURST INCInactiveMETHOCARBAMOL

DMF 2321956

CHRISTIAN BRUNNENGRABER AND COInactiveMETHOCARBAMOL

DMF 8661964

ORION CORP FERMIONInactiveMETHOCARBAMOL NF XV

DMF 40361980

TIANJIN MEDICINES & HEALTH PRODUCTS IMPORT AND EXPORT COInactiveMETHOCARBAMOL

DMF 41101981

ORGAMOL SAInactiveMETHOCARBAMOL

DMF 48281983

EASTMAN CHEMICAL COInactiveMETHOCARBAMOL USP

DMF 49801983

SYNTHAInactiveMETHOCARBAMOL

DMF 51361983

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVInactiveMETHOCARBAMOL

DMF 53741984

OMNICHEM NVInactiveMETHOCARBAMOL USP

DMF 56671985

ORION CORP LTDInactiveMETHOCARBAMOL

DMF 63891985

HEXAGON LABORATORIES INCInactiveMETHOCARBAMOL

DMF 64681986

LASA LABORATORIOS SAInactiveMETHOCARBAMOL

DMF 66421986

CIPLA LTDInactiveMETHOCARBAMOL

DMF 67051986

PENCO OF LYNDHURST INCInactiveMETHOCARBAMOL

DMF 67731987

SIANG TA PHARMACEUTICAL CO LTDInactiveMETHOCARBAMOL

DMF 108331994

CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTDInactiveMETHOCARBAMOL USP

DMF 130801998

LABORATORIES ARGENOI SLInactiveMETHOCARBAMOL, MAUFACTURED IN ZARAGOZA, SPAIN

DMF 140121999

BIDACHEM SPAInactiveMETHOCARBAMOL

DMF 149062000

BENTLEY API SLInactiveMETHOCARBAMOL

DMF 158752002

SEVEN STAR PHARMACEUTICAL CO LTDInactiveMETHOCARBAMOL DC 90%

DMF 202752007

ZHEJIANG JIANFENG HAIZHOU PHARMACEUTICAL CO LTDInactiveMETHOCARBAMOL

DMF 267682012

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 500MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Apr 30, 2021

No patent or exclusivity listings for this strength.

#002 — 750MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 30, 2021